Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Impact of second decline rate of BCR-ABL1 transcript on clinical outcome of chronic phase chronic myeloid leukemia patients on imatinib first-line.

Dulucq S, Etienne G, Morisset S, Klein E, Chollet C, Robbesyn F, Turcq B, Tigaud I, Hayette S, Nicolini FE, Mahon FX.

Ann Hematol. 2019 May;98(5):1159-1168. doi: 10.1007/s00277-019-03633-x. Epub 2019 Feb 23.

PMID:
30798348
2.

Could posture reflect welfare state? A study using geometric morphometrics in riding school horses.

Sénèque E, Lesimple C, Morisset S, Hausberger M.

PLoS One. 2019 Feb 5;14(2):e0211852. doi: 10.1371/journal.pone.0211852. eCollection 2019.

3.

Poor prognosis of chromosome 7 clonal aberrations in Philadelphia-negative metaphases and relevance of potential underlying myelodysplastic features in chronic myeloid leukemia.

Bidet A, Dulucq S, Smol T, Marceau-Renaut A, Morisset S, Coiteux V, Noël-Walter MP, Nicolini FE, Tigaud I, Luquet I, Struski S, Gaillard B, Penther D, Tondeur S, Nadal N, Hermet E, Véronèse L, Réa D, Gervais C, Theisen O, Terré C, Cony-Makhoul P, Lefebvre C, Gaillard JB, Radford I, Vervaeke AL, Barin C, Chapiro E, Nguyen-Khac F, Etienne G, Preudhomme C, Mahon FX, Roche-Lestienne C; Groupe Francophone de Cytogénétique Hématologique (GFCH) and the French Intergroup of Chronic Myeloid Leukemia (Fi-LMC).

Haematologica. 2019 Jun;104(6):1150-1155. doi: 10.3324/haematol.2018.208801. Epub 2018 Dec 20.

4.

Testing optimal methods to compare horse postures using geometric morphometrics.

Sénèque E, Morisset S, Lesimple C, Hausberger M.

PLoS One. 2018 Oct 31;13(10):e0204208. doi: 10.1371/journal.pone.0204208. eCollection 2018.

5.

Ponatinib evaluation and safety in real-life chronic myelogenous leukemia patients failing more than two tyrosine kinase inhibitors: the PEARL observational study.

Heiblig M, Rea D, Chrétien ML, Charbonnier A, Rousselot P, Coiteux V, Escoffre-Barbe M, Dubruille V, Huguet F, Cayssials E, Hermet E, Guerci-Bresler A, Amé S, Sackmann-Sala L, Roy L, Sobh M, Morisset S, Etienne G, Nicolini FE.

Exp Hematol. 2018 Nov;67:41-48. doi: 10.1016/j.exphem.2018.08.006. Epub 2018 Sep 5.

PMID:
30195076
6.

Long-term follow-up of de novo chronic phase chronic myelogenous leukemia patients on front-line imatinib.

Nicolini FE, Alcazer V, Cony-Makhoul P, Heiblig M, Morisset S, Fossard G, Bidet A, Schmitt A, Sobh M, Hayette S, Mahon FX, Dulucq S, Etienne G.

Exp Hematol. 2018 Aug;64:97-105.e4. doi: 10.1016/j.exphem.2018.05.003. Epub 2018 May 23.

PMID:
29800673
7.

High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia.

Plesa A, Dumontet C, Mattei E, Tagoug I, Hayette S, Sujobert P, Tigaud I, Pages MP, Chelghoum Y, Baracco F, Labussierre H, Ducastelle S, Paubelle E, Nicolini FE, Elhamri M, Campos L, Plesa C, Morisset S, Salles G, Bertrand Y, Michallet M, Thomas X.

World J Stem Cells. 2017 Dec 26;9(12):227-234. doi: 10.4252/wjsc.v9.i12.227.

8.

Chronic disseminated candidiasis and acute leukemia: Impact on survival and hematopoietic stem cell transplantation agenda.

Grateau A, Le Maréchal M, Labussière-Wallet H, Ducastelle-Leprêtre S, Nicolini FE, Thomas X, Morisset S, Michallet M, Ader F; Lyon HEMINF study Group.

Med Mal Infect. 2018 May;48(3):202-206. doi: 10.1016/j.medmal.2017.12.004. Epub 2018 Jan 4.

PMID:
29307444
9.

Preparation and Electrochemical Properties of NiCo2 O4 Nanospinels Supported on Graphene Derivatives as Earth-Abundant Oxygen Bifunctional Catalysts.

Kumar K, Loupias L, Canaff C, Morisset S, Pronier S, Morais C, Habrioux A, Napporn TW, Kokoh KB.

Chemphyschem. 2018 Feb 5;19(3):319-326. doi: 10.1002/cphc.201701038. Epub 2018 Jan 5.

PMID:
29207211
10.

Second tyrosine kinase inhibitor discontinuation attempt in patients with chronic myeloid leukemia.

Legros L, Nicolini FE, Etienne G, Rousselot P, Rea D, Giraudier S, Guerci-Bresler A, Huguet F, Gardembas M, Escoffre M, Ianotto JC, Noël MP, Varet BR, Pagliardini T, Touitou I, Morisset S, Mahon FX; French Intergroup for Chronic Myeloid Leukemias.

Cancer. 2017 Nov 15;123(22):4403-4410. doi: 10.1002/cncr.30885. Epub 2017 Jul 25.

11.

Association between mRNA expression of CD74 and IL10 and risk of ICU-acquired infections: a multicenter cohort study.

Peronnet E, Venet F, Maucort-Boulch D, Friggeri A, Cour M, Argaud L, Allaouchiche B, Floccard B, Aubrun F, Rimmelé T, Thiolliere F, Piriou V, Bohé J, Cazalis MA, Barbalat V, Monneret G, Morisset S, Textoris J, Vallin H, Pachot A, Lepape A; MIP Rea Study Group.

Intensive Care Med. 2017 Jul;43(7):1013-1020. doi: 10.1007/s00134-017-4805-1. Epub 2017 May 5.

12.

CML patients show sperm alterations at diagnosis that are not improved with imatinib treatment.

Nicolini FE, Alcazer V, Huguet F, Cony-Makhoul P, Heiblig M, Fort MP, Morisset S, Guerci-Bresler A, Soula V, Sobh M, d'Estaing SG, Daudin M, Etienne G.

Leuk Res. 2016 Sep;48:80-3. doi: 10.1016/j.leukres.2016.07.008. Epub 2016 Jul 22. No abstract available.

PMID:
27501271
13.

Decreased CX3CR1 messenger RNA expression is an independent molecular biomarker of early and late mortality in critically ill patients.

Friggeri A, Cazalis MA, Pachot A, Cour M, Argaud L, Allaouchiche B, Floccard B, Schmitt Z, Martin O, Rimmelé T, Fontaine-Kesteloot O, Page M, Piriou V, Bohé J, Monneret G, Morisset S, Textoris J, Vallin H, Blein S, Maucort-Boulch D, Lepape A, Venet F; MIP Rea Study Group.

Crit Care. 2016 Jun 30;20(1):204. doi: 10.1186/s13054-016-1362-x.

14.

Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method.

Dubois V, Detrait M, Sobh M, Morisset S, Labussière H, Giannoli C, Nicolini F, Moskovtchenko P, Mialou V, Ducastelle S, Rey S, Thomas X, Barraco F, Tedone N, Marry E, Garnier F, Bertrand Y, Michallet M.

Hum Immunol. 2016 Nov;77(11):1008-1015. doi: 10.1016/j.humimm.2016.02.004. Epub 2016 Feb 20.

PMID:
26902994
15.

The sequence to hydrogenate coronene cations: A journey guided by magic numbers.

Cazaux S, Boschman L, Rougeau N, Reitsma G, Hoekstra R, Teillet-Billy D, Morisset S, Spaans M, Schlathölter T.

Sci Rep. 2016 Jan 29;6:19835. doi: 10.1038/srep19835.

16.

Hyperhomocysteinemia and high doses of nilotinib favor cardiovascular events in chronic phase Chronic Myelogenous Leukemia patients.

Fossard G, Blond E, Balsat M, Morisset S, Giraudier S, Escoffre-Barbe M, Labussière-Wallet H, Heiblig M, Bert A, Etienne M, Drai J, Sobh M, Redonnet-Vernhet I, Lega JC, Mahon FX, Etienne G, Nicolini FE.

Haematologica. 2016 Mar;101(3):e86-90. doi: 10.3324/haematol.2015.135103. Epub 2015 Dec 3. No abstract available.

17.

HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.

Quintela A, Escuret V, Roux S, Bonnafous P, Gilis L, Barraco F, Labussière-Wallet H, Duscastelle-Leprêtre S, Nicolini FE, Thomas X, Chidiac C, Ferry T, Frobert E, Morisset S, Poitevin-Later F, Monneret G, Michallet M, Ader F; Lyon HEMINF Study Group.

J Infect. 2016 Feb;72(2):214-22. doi: 10.1016/j.jinf.2015.09.039. Epub 2015 Oct 28.

PMID:
26518057
18.

Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French-Swiss retrospective study.

Detrait M, Morisset S, Chalandon Y, Yakoub-Agha I, Dufossé F, Labalette M, Top I, Elsermans V, Barraco F, Quintela A, Tedone N, Michallet M, Raus N, Tiercy JM, Dubois V.

Bone Marrow Transplant. 2015 Oct;50(10):1316-20. doi: 10.1038/bmt.2015.157. Epub 2015 Jul 6.

PMID:
26146803
19.

Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Detrait MY, Morisset S, Peffault de Latour R, Yakoub-Agha I, Crocchiolo R, Tabrizi R, Bay JO, Chevalier P, Barraco F, Raus N, Vigouroux S, Magro L, Mohty M, Milpied N, Blaise D, Socié G, Michallet M.

Bone Marrow Transplant. 2015 Feb;50(2):253-8. doi: 10.1038/bmt.2014.244. Epub 2014 Nov 3.

PMID:
25365068
20.

Oral cyclosporine A in neonatal swines for transplantation studies.

Pan H, Gazarian A, Buff S, Solla F, Gagnieu MC, Leveneur O, Watrelot-Virieux D, Morisset S, Sobh M, Michallet MC, Roger T, Dubernard JM, Michallet M.

Immunopharmacol Immunotoxicol. 2015 Feb;37(1):19-25. doi: 10.3109/08923973.2014.975818. Epub 2014 Oct 30.

PMID:
25358107
21.

Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings.

Michallet M, Sobh M, Serrier C, Morisset S, Labussière H, Ducastelle S, Barraco F, Gilis L, Thomas X, Nicolini FE.

Leuk Lymphoma. 2015 Apr;56(4):999-1003. doi: 10.3109/10428194.2014.944518. Epub 2014 Aug 20.

PMID:
25029640
22.

High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.

Gilis L, Morisset S, Billaud G, Ducastelle-Leprêtre S, Labussière-Wallet H, Nicolini FE, Barraco F, Detrait M, Thomas X, Tedone N, Sobh M, Chidiac C, Ferry T, Salles G, Michallet M, Ader F; Lyon BK virus Study group.

Bone Marrow Transplant. 2014 May;49(5):664-70. doi: 10.1038/bmt.2013.235. Epub 2014 Feb 3.

PMID:
24488049
23.

Achieving deeper molecular response is associated with a better clinical outcome in chronic myeloid leukemia patients on imatinib front-line therapy.

Etienne G, Dulucq S, Nicolini FE, Morisset S, Fort MP, Schmitt A, Etienne M, Hayette S, Lippert E, Bureau C, Tigaud I, Adiko D, Marit G, Reiffers J, Mahon FX.

Haematologica. 2014 Mar;99(3):458-64. doi: 10.3324/haematol.2013.095158. Epub 2013 Dec 20.

24.

Mobilization of CD34(+)CD38(-) hematopoietic stem cells after priming in acute myeloid leukemia.

Plesa A, Chelghoum Y, Mattei E, Labussière H, Elhamri M, Cannas G, Morisset S, Tagoug I, Michallet M, Dumontet C, Thomas X.

World J Stem Cells. 2013 Oct 26;5(4):196-204. doi: 10.4252/wjsc.v5.i4.196.

25.

Evolving strategies with immunomodulating drugs and tandem autologous/allogeneic hematopoietic stem cell transplantation in first line high risk multiple myeloma patients.

Michallet M, Sobh M, El-Cheikh J, Morisset S, Sirvent A, Reman O, Cornillon J, Tabrizi R, Milpied N, Harousseau JL, Labussière H, Nicolini FE, Attal M, Moreau P, Mohty M, Blaise D, Avet-Loiseau H.

Exp Hematol. 2013 Dec;41(12):1008-15. doi: 10.1016/j.exphem.2013.08.003. Epub 2013 Aug 29.

PMID:
23994781
26.

Double umbilical cord blood transplantation for hematological malignancies: a long-term analysis from the SFGM-TC registry.

Wallet HL, Sobh M, Morisset S, Robin M, Fegueux N, Fürst S, Mohty M, Deconinck E, Fouillard L, Bordigoni P, Rio B, Sirvent A, Renaud M, Dhedin N, Tabrizi R, Maury S, Buzyn A, Michel G, Maillard N, Cahn JY, Bay JO, Yakoub-Agha I, Huynh A, Schmidt-Tanguy A, Lamy T, Lioure B, Raus N, Marry E, Garnier F, Balère ML, Gluckman E, Rocha V, Socié G, Blaise D, Milpied N, Michallet M.

Exp Hematol. 2013 Nov;41(11):924-33. doi: 10.1016/j.exphem.2013.05.297. Epub 2013 Jul 2.

PMID:
23831606
27.

The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis.

Nicolini FE, Ibrahim AR, Soverini S, Martinelli G, Müller MC, Hochhaus A, Dufva IH, Kim DW, Cortes J, Mauro MJ, Chuah C, Labussière H, Morisset S, Roche-Lestienne C, Lippert E, Hayette S, Peter S, Zhou W, Maguer-Satta V, Michallet M, Goldman J, Apperley JF, Mahon FX, Marin D, Etienne G.

Haematologica. 2013 Oct;98(10):1510-6. doi: 10.3324/haematol.2012.080234. Epub 2013 May 28.

28.

High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia.

Hayette S, Thomas X, Jallades L, Chabane K, Charlot C, Tigaud I, Gazzo S, Morisset S, Cornillet-Lefebvre P, Plesa A, Huet S, Renneville A, Salles G, Nicolini FE, Magaud JP, Michallet M.

PLoS One. 2012;7(12):e51527. doi: 10.1371/journal.pone.0051527. Epub 2012 Dec 10.

29.

Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: long-term prospective multicenter study.

Michallet M, Socié G, Mohty M, Sobh M, Bay JO, Morisset S, Labussière-Wallet H, Tabrizi R, Milpied N, Bordigoni P, El-Cheikh J, Blaise D.

Exp Hematol. 2013 Feb;41(2):127-33. doi: 10.1016/j.exphem.2012.10.008. Epub 2012 Oct 23.

PMID:
23089183
30.

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients.

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Cancer. 2013 Jan 1;119(1):107-14. doi: 10.1002/cncr.27686. Epub 2012 Jun 28.

31.

Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.

Detrait M, Dubois V, Sobh M, Morisset S, Tedone N, Labussière H, Gillis L, Barraco F, Cannas G, Ducastelle S, Fatoum J, Thomas X, Chelgoum Y, Nicolini FE, Michallet M.

Exp Hematol. 2012 Oct;40(10):792-9. doi: 10.1016/j.exphem.2012.06.003. Epub 2012 Jun 12.

PMID:
22705505
32.

Palatal sclerotherapy for the treatment of intermittent dorsal displacement of the soft palate in 51 standardbred racehorses.

Jean D, Picandet V, Céleste C, Macieira S, Cesarini C, Morisset S, Rossier Y, Marcoux M.

Can Vet J. 2011 Nov;52(11):1203-8.

33.

Phase II prospective study of treosulfan-based reduced-intensity conditioning in allogeneic HSCT for hematological malignancies from 10/10 HLA-identical unrelated donor.

Michallet M, Sobh M, Milpied N, Bay JO, Fürst S, Harousseau JL, Mohty M, Nicolini FE, Labussière H, Tedone N, Morisset S, Vigouroux S, Baumgart J, Tabrizi R, Blaise D.

Ann Hematol. 2012 Aug;91(8):1289-97. doi: 10.1007/s00277-012-1429-y. Epub 2012 Feb 25.

PMID:
22362122
34.

Allogeneic stem cell transplantation for patients harboring T315I BCR-ABL mutated leukemias.

Nicolini FE, Basak GW, Soverini S, Martinelli G, Mauro MJ, Müller MC, Hochhaus A, Chuah C, Dufva IH, Rege-Cambrin G, Saglio G, Michallet M, Labussière H, Morisset S, Hayette S, Etienne G, Olavarria E, Zhou W, Peter S, Apperley JF, Cortes J.

Blood. 2011 Nov 17;118(20):5697-700. doi: 10.1182/blood-2011-07-367326. Epub 2011 Sep 16.

35.

Geometric morphometrics as a tool for improving the comparative study of behavioural postures.

Fureix C, Hausberger M, Seneque E, Morisset S, Baylac M, Cornette R, Biquand V, Deleporte P.

Naturwissenschaften. 2011 Jul;98(7):583-92. doi: 10.1007/s00114-011-0803-2. Epub 2011 May 14.

PMID:
21573691
36.

Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole.

Michallet M, Sobh M, Morisset S, Kraghel S, Nicolini FE, Thomas X, Bienvenu AL, Picot S, Nicolle MC, Vanhems P.

Med Mycol. 2011 Oct;49(7):681-7. doi: 10.3109/13693786.2011.557668. Epub 2011 Feb 11.

PMID:
21314250
37.

[The histaminergic system: a target for innovative treatments of cognitive deficits].

Motawaj M, Burban A, Davenas E, Gbahou F, Faucard R, Morisset S, Arrang JM.

Therapie. 2010 Sep-Oct;65(5):415-22. doi: 10.2515/therapie/2010058. Epub 2010 Dec 13. French.

PMID:
21144476
38.

The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry.

Michallet M, Sobh M, Milligan D, Morisset S, Niederwieser D, Koza V, Ruutu T, Russell NH, Verdonck L, Dhedin N, Vitek A, Boogaerts M, Vindelov L, Finke J, Dubois V, van Biezen A, Brand R, de Witte T, Dreger P; Chronic Leukemia Working Party of the EBMT.

Leukemia. 2010 Oct;24(10):1725-31. doi: 10.1038/leu.2010.165. Epub 2010 Aug 12.

PMID:
20703257
39.

Study of the sticking of a hydrogen atom on a graphite surface using a mixed classical-quantum dynamics method.

Morisset S, Ferro Y, Allouche A.

J Chem Phys. 2010 Jul 28;133(4):044508. doi: 10.1063/1.3463001.

PMID:
20687664
40.

Pharmacological, neurochemical, and behavioral profile of JB-788, a new 5-HT1A agonist.

Picard M, Morisset S, Cloix JF, Bizot JC, Guerin M, Beneteau V, Guillaumet G, Hevor TK.

Neuroscience. 2010 Sep 1;169(3):1337-46. doi: 10.1016/j.neuroscience.2010.05.040. Epub 2010 May 24.

PMID:
20580787
41.

Effects of betahistine at histamine H3 receptors: mixed inverse agonism/agonism in vitro and partial inverse agonism in vivo.

Gbahou F, Davenas E, Morisset S, Arrang JM.

J Pharmacol Exp Ther. 2010 Sep 1;334(3):945-54. doi: 10.1124/jpet.110.168633. Epub 2010 Jun 8.

PMID:
20530654
42.

Recessive isolated growth hormone deficiency and mutations in the ghrelin receptor.

Pantel J, Legendre M, Nivot S, Morisset S, Vie-Luton MP, le Bouc Y, Epelbaum J, Amselem S.

J Clin Endocrinol Metab. 2009 Nov;94(11):4334-41. doi: 10.1210/jc.2009-1327. Epub 2009 Sep 29.

PMID:
19789204
43.

Histamine H(3) receptor-mediated signaling protects mice from cerebral malaria.

Beghdadi W, Porcherie A, Schneider BS, Morisset S, Dubayle D, Peronet R, Dy M, Louis J, Arrang JM, Mécheri S.

PLoS One. 2009 Jun 23;4(6):e6004. doi: 10.1371/journal.pone.0006004.

44.

Quantum dynamic of sticking of a H atom on a graphite surface.

Morisset S, Allouche A.

J Chem Phys. 2008 Jul 14;129(2):024509. doi: 10.1063/1.2952685.

PMID:
18624540
45.

Palatal sclerotherapy: a potentially useful treatment of intermittent dorsal displacement of the soft palate in juvenile standardbred racehorses.

Marcoux M, Picandet V, Céleste C, Macieira S, Morisset S, Rossier Y, Schambourg M, Jean D.

Can Vet J. 2008 Jun;49(6):587-91.

46.

Arthroscopic surgical approach and intra-articular anatomy of the equine suprapatellar pouch.

Vinardell T, David F, Morisset S.

Vet Surg. 2008 Jun;37(4):350-6. doi: 10.1111/j.1532-950X.2008.00388.x.

PMID:
18564259
47.

Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America.

Morisset S, Peyron F, Lobry JR, Garweg J, Ferrandiz J, Musset K, Gomez-Marin JE, de la Torre A, Demar M, Carme B, Mercier C, Garin JF, Cesbron-Delauw MF.

Microbes Infect. 2008 Jun;10(7):742-7. doi: 10.1016/j.micinf.2008.04.001. Epub 2008 Apr 9.

PMID:
18539501
48.

Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors.

Davenas E, Rouleau A, Morisset S, Arrang JM.

J Pharmacol Exp Ther. 2008 Aug;326(2):406-13. doi: 10.1124/jpet.107.135368. Epub 2008 May 12.

PMID:
18474684
49.

Digestive enzyme concentrations and activities in healthy pancreatic tissue of horses.

Lorenzo-Figueras M, Morisset SM, Morisset J, Lainé J, Merritt AM.

Am J Vet Res. 2007 Oct;68(10):1070-2.

PMID:
17916012
50.

Constitutive activity of the histamine H3 receptor.

Arrang JM, Morisset S, Gbahou F.

Trends Pharmacol Sci. 2007 Jul;28(7):350-7. Epub 2007 Jun 15. Review.

PMID:
17573125

Supplemental Content

Loading ...
Support Center